Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adamis, Astrazeneca, Bavarian Nordic, Celltrion, Clarity, Daewoong, Daiichi Sankyo, Elpiscience, Innocare, Innovent, Insilico Medicine, Jacobio, Kazia, Lynk, Olipass, Oncocross, Pharmabcine, Polyactiva, Recce, Simcere, Takeda, TFF, Transcenta.